Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:A072020) announces a share repurchase program. Under the program, the company will repurchase up to 100,000 shares, pursuant to a trust contract with Hana Financial Investment Co., Ltd. The purpose of the program is to stabilize stock price through shareholder value enhancement. The program will expire on January 12, 2023.

As of October 12, 2022, the company had 200,000 shares in treasury within scope available for dividend and had 1,313 shares in treasury under other acquisitions.